Manning & Napier Group, LLC / VRTX
Manning & Napier Group, LLC’s Vertex Pharmaceuticals Inc Position
Does Manning & Napier Group, LLC own Vertex Pharmaceuticals Inc (VRTX)? Yes — 229.6K shares worth $96M (+1.10% of its 13F portfolio) as of Q1 2024, down from 237.3K shares the prior filed quarter.
Position Value
$96M
Q1 2024
Shares
229.6K
% of Portfolio
+1.10%
Quarters Held
21
currently held
Position History VRTX
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2024 | 229.6K | $96M | +1.10% |
| Q4 2023 | 237.3K | $97M | +1.15% |
| Q3 2023 | 249.1K | $87M | +1.07% |
| Q2 2023 | 256.6K | $90M | +1.03% |
| Q1 2023 | 264.3K | $83M | +0.97% |
| Q4 2022 | 271.9K | $79M | +0.97% |
| Q3 2022 | 276.9K | $80M | +1.05% |
| Q2 2022 | 280.0K | $79M | +0.91% |
| Q1 2022 | 694.8K | $181M | +1.73% |
| Q4 2021 | 874.0K | $192M | +1.60% |
| Q3 2021 | 872.9K | $158M | +1.36% |
| Q2 2021 | 897.1K | $181M | +1.48% |
| Q1 2021 | 858.2K | $184M | +1.57% |
| Q4 2020 | 392.4K | $93M | +0.86% |
| Q3 2020 | 56.9K | $15M | +0.16% |
| Q2 2020 | 54.1K | $16M | +0.17% |
| Q1 2020 | 53.3K | $13M | +0.15% |
| Q4 2019 | 219.2K | $48M | +0.52% |
| Q3 2019 | 237.7K | $40M | +0.45% |
| Q2 2019 | 383.3K | $70M | +0.76% |
| Q1 2019 | 300.6K | $55M | +0.61% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Manning & Napier Group, LLC’s full portfolio or all institutional holders of VRTX.